Circassia Raises £15 Million
Circassia Ltd., a UK-based drug company focused on allergies, has raised £15 million in third-round funding. Imperial Innovations led the round, and was joined by return backers Invesco Perpetual and Lansdowne Partners.
11 December 2009•2 mins read
